Answers are grounded in this paper and cite their sources.
Most breast cancers are driven by a transcription factor called oestrogen receptor (ER). Understanding the mechanisms of ER activity in breast cancer has been a major research interest and recent genomic advances have revealed extraordinary insights into how ER mediates gene transcription and what occurs during endocrine resistance. This review discusses our current understanding on ER activity, with an emphasis on several evolving, but important areas of ER biology.
No takes yet. Share an insight, caveat, or question.
Jason S. Carroll (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: